GAIXOTASUN ERREUMATIKOAK
GlaxoSmithKline (Spain)
Madrid, EspañaGlaxoSmithKline (Spain)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Budget impact analysis of subcutaneous belimumab in patients with systemic lupus erythematosus in Spain
ClinicoEconomics and Outcomes Research, Vol. 11, pp. 757-765